VTE risk in patients with ovarian cancer undergoing neoadjuvant chemotherapy.
Ovarian cancer is the ninth most common type of cancer and the seventh most common cause of cancer death in women . In...
LATEST ARTICLES
Bleeding risk, cancer, and atrial fibrillation. Waiting for ICTHIC 2022
Cancer and atrial fibrillation A connection exists between cancer and atrial fibrillation (AF) as cancer is...
Prognostic markers in patients with advanced cancer. Waiting for ICTHIC 2022
Estimation of prognosis is of utmost importance when managing patients with advanced cancer: it helps make decisions...
Tools to raise thrombosis awareness in patients with cancer: a lesson from the EMPOWER study
Cancer-associated thrombosis (CAT) is the most frequent cause of death in patients with cancer after cancer itself . In...
Does warfarin increase overall survival compared to LMWH in CAT treatment?
The treatment of cancer-associated thrombosis (CAT) has changed over the last 20 years, going from warfarin up to the...
What information should be given to patients with cancer, and when should it be given on the cancer care pathway?
During the ICTHIC webinar “Joint forces: the Patient & the Multi-disciplinary Team working together to...